Glycobiology and human diseases

Harvard Medical School Center for Glycoscience
Free download. Book file PDF easily for everyone and every device. You can download and read online Glycobiology and human diseases file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Glycobiology and human diseases book. Happy reading Glycobiology and human diseases Bookeveryone. Download file Free Book PDF Glycobiology and human diseases at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Glycobiology and human diseases Pocket Guide.

Consideration of the unique structure, biosynthesis, degradation and function of glycans forms a basis for consideration of critical changes in many of these processes in disease, and lays the ground work for the chapters that follow. The reference list of this chapter includes many recently published reviews, monographs and collective comprehensive editions, and summarizes basic directions in glycobiology that may help readers expand their knowledge and skills in both theoretical and experimental areas of this science.

Glycobiology And Human Diseases. Methods of structural analysis of glycosaminoglycans GAG , applications of these methods for identifi cation of lysosomal storage diseases LSD and GAG participation in the development of Lyme disease are reviewed in Chapters 2 Azadi and Heiss , 3 Bruggink et al.

Various methodical approaches for GAG analysis are described as well as changes of these biopolymers in different types of LSD, and the role of GAG in tissue tropism for the Lyme disease spirochete. Chapter 5 Hartshorn highlights the role of viral envelope protein glycosylation in pathogenesis of infl uenza A virus. In collaboration with experts in crystallography, molecular modeling, and molecular dynamics, the author and his colleagues have determined the molecular mechanism of binding of surfactant protein D SP-D to the infl uenza A virus hemagglutinin, and established the basis for increased inhibitory activity of mutant versions of SP-D.

These studies provide the fi rst detailed molecular mechanism for viral inhibition by an innate lectin inhibitor based on shared expertise in virology, structural biology, protein chemistry, and glycomics. Save my name, email, and website in this browser for the next time I comment. Sign in.

Related Articles

Log into your account. Forgot your password? Password recovery.

  • Beyond Casablanca: M. A. Tazi and the Adventure of Moroccan Cinema.
  • Article tools!
  • Glycobiology Goes to the Ball.
  • Glycobiology and Human Diseases - AbeBooks: .
  • The Feasts and Seasons of John F. Kelly.
  • Materials for Architects and Builders (4th edition)!

Recover your password. Get help. A common feature of protozoan parasites and helminths is the synthesis of glycoconjugates and glycan-binding proteins for protection and to interact and respond to changes in their environment. To address the many challenges associated with the study of the structure, the biosynthesis, and the biology of parasitic glycans, the authors of this article have established GlycoPar, a European Marie Curie training program steered by some of the world's academic leaders in the field of parasite glycobiology, in close association with European industrial enterprises.

The main scientific goal of this network is the description of novel paradigms and models by which parasite glycoconjugates play a role in the successful colonization of the different hosts. By means of a training-through-research program, the aim of the network is to contribute to the training of a generation of young scientists capable of tackling the challenges posed by parasite glycobiology. Due to the complexity of their life cycles, parasites need to sequentially exploit various host species to complete the different stages involved in their survival and development.

The interactions with their different hosts are critical for the completion of each life stage and are often based on carbohydrate recognition. In particular, parasites have developed different strategies to escape the immune and defense systems of the different infected organisms.

Glycobiology cancer - Oxford Brookes University

Their surfaces are covered by glycoconjugates of varied natures, often of types absent from mammals. This so-called glycocalyx is protective against the host defense systems but may also be implicated in "hijacking" proteins involved in host innate immunity Fig 1 [ 2 , 3 ]. Thus, through a "glycan gimmickry" designated process, helminths express host-like glycans that interact with host lectins to modulate the immune response [ 4 ].

Furthermore, the walls that protect different parasitic cysts from harsh environments are also rich in polysaccharides and polysaccharide-binding lectins [ 5 ]. Thereby, glycans are crucial for parasite virulence and survival.

The clinical relevance of glycobiology

False-color scanning electron microscopy EM of a T. Transmission EM of ruthenium-red stained ultrathin sections showing the surface glycocalyx of T. Scheme summarizing the main surface glycosylphosphatidylinositol GPI -anchored EP- and GPEET-procyclins and trans-sialidases and transmembrane including polytopic glycoproteins and glycolipids expressed by T. Open rectangles linked to GPI molecules represent side chains characteristic of surface glycoconjugates from procyclic T. EM images obtained by C. Rose, A.


Structural characterization of N-linked oligosaccharides of laminin from rat kidney: changes during diabetes and modulation by dietary fiber and butyric acid. Cell Microbiol. Curr Opin Chem Biol. Amblyomma americanum tick calreticulin binds C1q but does not inhibit activation of the classical complement cascade. In light of this evidence, the E protein glycosylation seems to represent one of the factors conferring different vector and host competence. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand.

Beckett, L. Tetley, I. Prior, and A. Since glycans are central to host—parasite interactions, their study constitutes a fertile, but currently largely unexploited, area for therapeutic applications. Research in parasite glycosylation provides new opportunities for the discovery of vaccine candidates and for the development of novel chemotherapy approaches and diagnostic tools. Nevertheless, there are many challenges associated with working with parasites, including problems in obtaining sufficient amounts of biological material for analytical purposes, difficulties of culturing the different life stages, and, on occasion, the lack of tools for functional genomics and molecular biology approaches.

Glycans add another level of difficulty to these studies, due to their extensive diversity and exquisite complexity. In contrast to nucleic acid and proteins, their biosynthesis is only indirectly template-driven and generates an important amount of structural variability in biological systems.

This complexity is critical in molecular recognition events including cell—cell, cell—matrix, and cell—molecule interactions during essential steps of pathogenesis. Thus, the thorough characterization of parasite glycobiology requires systematic approaches that focus on the description of the glycosylation precursors, the glycan-processing enzymes, and the structure and functional significance of parasitic glycans. In addition, most of the medically and veterinarially important parasites are phylogenetically ancient organisms and represent good models for studying evolutionary aspects of eukaryotic glycosylation.

Thus, the study of parasite glycans may unravel novel mechanisms also present in higher eukaryotes. Excellent examples are the description of the structure of glycosylphosphatidylinositol GPI membrane anchors in African trypanosomes [ 7 ] or the discovery of the glycoprotein quality control cycle, thanks to seminal studies on the N-glycosylation pathway of trypanosomatid parasites [ 8 ].

Interestingly enough, different parasitic protists present variable lengths in their N-glycan precursors that directly affect this N-glycan-dependent quality control system [ 9 ]. Glycan synthesis requires activated monosaccharides, mainly in the form of nucleotide sugars that will be used by glycosyltransferase enzymes as glycosyl donor substrates in glycosylation reactions. Therefore, the presence of activated sugars is a prerequisite for glycan biosynthesis, and their availability influences the glycan structures that may be synthesized by a parasite the glycome.

Thus, valuable information about the glycome can be gained from the identification and quantification of the sugar nucleotide pools maintained during the life stages of different parasites. Sugar nucleotides are formed by de novo pathways requiring the bioconversion of an existing sugar or sugar nucleotide or by salvage pathways involving the activation of the sugar using a kinase and a pyrophosphorylase.

The conservation of specific biosynthetic pathways in the parasite genomes are strong hints of the presence of nucleotide sugar pools [ 11 , 12 ]. Monosaccharide activation usually takes place in the cytoplasm, although in Trypanosoma brucei brucei and possibly other kinetoplastid parasites, these biosynthetic reactions occur in a specific organelle called glycosome [ 13 ]. This metabolic compartmentalization and the study of the transporters involved also offer new opportunities for the selective inhibition of crucial glycosylation reactions in parasites.

Glycan biosynthesis and cellular compartments involved in the glycosylation process.

  • A glycobiology review: carbohydrates, lectins, and implications in cancer therapeutics.
  • How to Guzzle Your Garden.
  • The Worst-Case Scenario Pocket Guide: Retirement.
  • The political economy of international trade law: essays in honour of Robert E. Hudec.

Sugars are carried across the plasma membrane into cells or are salvaged from degraded glycoconjugates at lysosomes. Through biosynthetic and interconversion reactions, monosaccharides are activated into different nucleotide sugars. Sugar activation generally takes place in the cytoplasm, although several enzymes involved in sugar nucleotide biosynthesis in T.

Glycosyltransferases and other glycan-processing enzymes define the assembly and final structure of glycans that are secreted or located in the cell surface, forming a protective glycocalyx. Glycosyltransferases transfer sugar moieties from activated donors to specific acceptor molecules, generating glycosidic linkages between carbohydrates or between a carbohydrate and a noncarbohydrate moiety. Therefore, they define the assembly and final structure of glycan chains, which can be linear or branched and of various lengths. Glycoside hydrolases, the enzymes that hydrolyze glycosidic bonds, form another main group of carbohydrate-active enzymes that also play important roles in determining the final structure of mature glycans.

The combined action of several of these enzymes in the secretory pathway leads to a vast and diverse array of glycan structures. Additionally, parasitic glycan-binding proteins interact with specific parasite and host glycan structures present in the surface of cells. Sequence-based families of glycosyltransferases, glycoside hydrolases, and carbohydrate-binding proteins group together according to their function, indicating that the acquisition of the specificities of these enzymes evolved from common progenitors.

Therefore, despite the huge diversity of glycans, the activities and molecular mechanism of the enzymes involved in their biosynthesis can often be inferred from their sequences [ 14 ].

Advancing Research into Glycomics

Summary. This book discusses glycobiology and various forms of human diseases. Topics covered include immunoglobulins, inflammation and glycosylation. Glycans in Physiology and Disease. Publication Glycans in Acquired Human Diseases · Glycosylation Essentials of Glycobiology [Internet]. 3rd edition.

Nevertheless, because of the substantial evolutionary distance between protozoan parasites and higher eukaryotes, it can be challenging to define the precise function of specific parasitic glycosyltransferases from sequence similarity [ 15 , 16 ] or by inference from the final structures determined by a particular glycosylation pathway [ 17 , 18 ]. Glycosyltransferases and other glycan-processing enzymes involved in the biosynthesis of glycans essential for the survival and infectivity of parasites might be exploited as drug targets.

Therefore, increasing our knowledge of the different parasitic glycosylation pathways and their biological relevance will contribute to uncovering the therapeutic potential therein. The characterization and quantification of the complete set of glycans and glycoconjugates made by a cell or organism at a given time is defined as glycomics. Since glycosylation is the most structurally diverse, and one of the most abundant, protein and lipid modifications, the description of the spectrum of all glycan structures—the glycome—of even just a single cell type is a huge challenge.

Nevertheless, to shed light on the structure—function relationship of parasite glycans at the molecular level, a detailed knowledge of their structures is an important prerequisite that can only be achieved through the use of different analytical methodologies and glycoproteomics and glycolipidomics strategies. Currently, mass spectrometry is a key tool in glycomics and has revealed highly unusual glycans from a number of unicellular and metazoan parasites [ 19 ]. Host receptor molecules can specifically recognize glycans, and these glycan—receptor interactions are related to migration, invasion, adhesion, toxin production, and other essential processes during the course of parasitic infections.

Glycobiology and Human Diseases

By a thorough exploration of the glycomic capacity of parasites and its influence on the interactions with their hosts, the code defined by the different glycan structures can be gradually characterized. In addition, glycomic approaches can be illuminating in the discovery of novel antigenic glycans for the development of diagnostic tools or glycovaccines. An important step in this respect would be the development of glycan microarrays reflecting parasite glycomes in order to identify binding partners in the human proteome, such as components of the innate immune system. Similarly, identifying host glycan structures recognized by parasite proteins with lectin-like properties will be fundamental for describing host—parasite interactions in parasitic diseases.

Glycobiology has become a well-established area of study in recent decades and is currently providing drug targets against several pathogens and diseases. Ethambutol, Caspofungin, Zanamivir, and Oseltamivir are well-known examples of commercial drugs in use—as therapies against tuberculosis, candidiasis, aspergillosis, and influenza—that target glycosylation and carbohydrate processing.

Glycobiology and Human Diseases

Similarly, bacterial polysaccharide—protein conjugate vaccines have recently revolutionized vaccination strategies.